Phase 1/2 Study of UI-102 in Selected Advanced Cancers
Phase 1/2 Study of UI-102 in Selected Advanced Cancers
Recruiting · NCT07605962 · Registry updated 2026-06-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1/2 Study of UI-102 in Selected Advanced Cancers | Advanced Cancer | Recruiting | Phase 1 / Phase 2 | 2026-06-03 | NCT07605962 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| United Immunity, co., Ltd. | 1 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| NEXT Oncology | Dallas | United States | 4 |
| NEXT Oncology | San Antonio | United States | 70 |
| NEXT Oncology | Houston | United States | 5 |